Johanna M. Gijtenbeek
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 02, 2026
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort study.
Journal: The Lancet. Haematology
Published: January 08, 2026
Adult ependymoma: results from the Dutch Brain Tumour Registry on primary treatment and survival.
Journal: Journal of neuro-oncology
Published: June 16, 2025
[18F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial.
Journal: Trials
Published: November 11, 2024
Polyradiculitis as a Neurological Complication Associated with Adagrasib: A Case Report.
Journal: Case reports in oncology
Published: August 16, 2024
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol.
Journal: Journal of neuro-oncology
Published: January 30, 2023
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patients.
Journal: Acta neuropathologica communications
Published: February 01, 2022
Revised guideline 'Brain metastases': More treatment options
Journal: Nederlands tijdschrift voor geneeskunde
Published: December 17, 2020
Immune Checkpoint Inhibitor-related Guillain-Barré Syndrome: A Case Series and Review of the Literature.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: November 14, 2020
Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 11, 2018
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Journal: The Lancet. Oncology
Published: May 08, 2016
Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 12, 2015
Last Updated: 09/26/2026